A white circular icon with lines and nodes representing a network

Global Substance Registration System

Project Charter

The goal of the system is to make it easier for regulators and other stakeholders to exchange information about substances in medicines, supporting scientific research on the use and safety of the ingredients in medicinal products.

The Challenge

The GSRS is a registration system for the ingredients in medicinal products. The creation of the GSRS was a collaborative effort between the FDA, NIH and EMA, and driven by the need to accurately track the global supply chain of ingredients in regulated products.

In practice, the system serves a multiplicity of use cases beyond providing a standard substance registry, and there is limited stakeholder governance to guide ongoing and future system development, and to provide financial stability.

What does the project aim to achieve?

In order to address the current challenges with the GSRS system, and to build a vision for the future that could include the harmonisation of regulatory systems, the proposal is to create a consortium of GSRS stakeholders led by the Pistoia Alliance.

The proposed Consortia would form the governing body for the GSRS. The mission of the Consortia would be to develop a shared vision for GSRS, develop and enact a business plan to attain the vision, and guide ongoing development and maintenance of the system.

The consortia should, at a minimum, include stakeholders from:

  • Pharmaceutical companies
  • Health Authorities including, but ideally not limited to the FDA and EMA
  • NIH/NCATS
  • US Pharmacopeia

The multi-year vision, strategy and business plan should include the:

  • As is state of the GSRS and the vision for the future
  • Viable governance framework
  • Business model with a sustainable funding mechanism
  • Architectural analysis
  • Process for release management including testing, documentation, release schedules, implementation and support guides
  • Support models
  • Alignment on standards, terminologies and minimum metadata requirements.

We propose initiating a multi-stakeholder project to define the multi-year strategy, vision and governance framework, and to determine if there is a viable business model to sustain the Consortia.

The resulting deliverables will include:

  • Development of a business case that meets the needs of all primary stakeholders with a viable funding model for development and maintenance of the system
  • Agreement on a governance approach that balances immediate and long-term needs and delivers value to all stakeholders
  • A governance, development model and system architecture that works with in today’s fast changing business, regulatory and technology environments

Get Involved

Talk to to our project manager, to learn more

Contact Birthe Nielsen

Project Partners

  • GSK logo
Save the Date

Accelerating Innovations - London

April 13-15, 2026

Once again we will be hosting the Annual Spring conference at the Royal Society of Medicine, London. Registration opens January 1st, 2026.Once again we will be hosting the Annual Spring conference at the Royal Society of Medicine, London. Registration opens January 1st, 2026.

Our Events

26 Nov 2025

FAIR Business Value Framework: An Introduction

Book Now
02 Dec 2025

Japan-Only Member Call | 日本限定メンバーコール

Book Now
03 Dec 2025

IDMP Ontology Community of Interest Meeting

Book Now
04 Dec 2025

Persistent Challenges in Cheminformatics

Book Now
04 Dec 2025

Pharmaceutical CMC Process Ontology CoI Meeting

Book Now
10 Dec 2025

From Standards to Action: Implementing Regulatory Data Use Cases with Pistoia Alliance IDMP-Ontology

Book Now
11 Dec 2025

UK Life Science Informatics Forum – Christmas 2025

Book Now